Cargando…

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway

Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielke, Dieter, Bandawe, Gama, Pollara, Justin, Abrahams, Melissa-Rose, Nyanhete, Tinashe, Moore, Penny L., Thebus, Ruwayhida, Yates, Nicole L., Kappes, John C., Ochsenbauer, Christina, Garrett, Nigel, Abdool Karim, Salim, Tomaras, Georgia D., Montefiori, David, Morris, Lynn, Ferrari, Guido, Williamson, Carolyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919271/ https://www.ncbi.nlm.nih.gov/pubmed/31921139 http://dx.doi.org/10.3389/fimmu.2019.02875

Ejemplares similares

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
por: Mielke, Dieter, et al.
Publicado: (2021)

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes
por: Pollara, J, et al.
Publicado: (2012)

Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
por: Moore, Penny L., et al.
Publicado: (2009)

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
por: Mielke, Dieter, et al.
Publicado: (2022)

The Yin and Yang of ADCC-Mediating Antibodies
por: Robert-Guroff, Marjorie
Publicado: (2016)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
por: Semmes, Eleanor C., et al.
Publicado: (2023)

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
por: Pollara, Justin, et al.
Publicado: (2013)

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
por: Scheepers, Cathrine, et al.
Publicado: (2020)

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies
por: Lallemand, Christophe, et al.
Publicado: (2017)

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
por: Rademeyer, Cecilia, et al.
Publicado: (2016)

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
por: Rademeyer, Cecilia, et al.
Publicado: (2017)

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
por: Natsume, Akito, et al.
Publicado: (2009)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
por: Nyanhete, Tinashe E., et al.
Publicado: (2021)

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.
por: Pehamberger, H., et al.
Publicado: (1980)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
por: Iida, Shigeru, et al.
Publicado: (2009)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

1008. Presence of Antibody Dependent Cell Cytotoxicity (ADCC) Functional Antibodies that Target a Complex Gp41 Epitope Correlates with Long-term Non-progression and ADCC is Maintained with Mutants Using Germline Heavy Chain Variable Gene Sequence of VH1-02 Gene
por: Baron, Sarah, et al.
Publicado: (2021)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
por: Li, Kan, et al.
Publicado: (2023)

Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)
por: Jäpel, M., et al.
Publicado: (1994)

Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination
por: Dugast, A, et al.
Publicado: (2012)

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial
por: Williams, WB, et al.
Publicado: (2012)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus
por: Vlahava, Virginia-Maria, et al.
Publicado: (2021)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
por: Yaffe, Zak A., et al.
Publicado: (2023)

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
por: Archary, D, et al.
Publicado: (2016)

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
por: van Eeden, Charmaine, et al.
Publicado: (2018)

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2012)

Preventing escape from neutralizing antibodies
por: Brown, Matthew
Publicado: (2020)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
por: Parsons, Matthew S., et al.
Publicado: (2015)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
por: Kline, James Bradford, et al.
Publicado: (2017)

Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV
por: Wang, Shixia, et al.
Publicado: (2022)

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2013)

The Cat and Mouse of HIV-1 Antibody Escape
por: Mascola, John R.
Publicado: (2009)

Using impedance-based approaches for measuring cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC)
por: Lamarche, Brandon, et al.
Publicado: (2015)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
por: Tso, For Yue, et al.
Publicado: (2021)

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
por: Mkhize, Nonhlanhla N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o7a18dc8ut0fo91tif8fne686n